Xcout IntelPatensee, Inc.
Patensee develops a contactless imaging and artificial intelligence system designed for hemodialysis clinics to monitor patient vascular access sites. The technology aims to standardize physical examinations and enable the early prediction of stenosis and other complications for dialysis patients.
Subscribe to see Patensee, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Patensee, Inc. at a glance
Patensee, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $1.6M in February 2024. Xcout tracks 9 named people at Patensee, Inc., including Paul A. Neeb (President and CEO).
Patensee, Inc. leadership
- Paul A. NeebPresident and CEO
- Paul NeebPresident, CEO and Director
- Eileen KeInterim President, US
- Noam TaichlerCFO
- Hagay DroriCo-founder, GM Israel
- Eran CohenVP of Business Development
3 more named people on record for Patensee, Inc., with roles, board committees and tenure — see the full roster →
Patensee, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Patensee, Inc. competitors
A few of Patensee, Inc.'s closest competitors — see the full list of competitors and alternatives →
Vibronix, Inc. is a medical device and technology company headquartered in Indiana, USA, established in 2013. The company develops innovative medical imaging and sensing devices utilizing optical and acoustic sensing alongside machine learning.
Berman Medical is a medical technology company developing an aesthetics and dermatology platform focused on facial injections. Their system combines advanced imaging, spatial tracking, and artificial intelligence to provide clinicians with real-time, patient-specific anatomical navigation during treatments.
Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.
Vasoptic Medical, Inc. is a biotechnology company that develops non-invasive medical imaging and monitoring devices for evaluating vascular and blood flow status.
Pictura Bio is a medical technology company developing a one-minute pathogen detection platform utilizing proprietary hardware and computer vision for infectious disease diagnostics. Its point-of-care system, which includes the PIC-ID and VISTA reader technologies, provides rapid identification and differentiation of pathogens to assist frontline healthcare providers.
AWAK Technologies (now operating as Vivance) develops medical technology solutions for comprehensive kidney care, including ultraportable and wearable dialysis devices, point-of-care dialysis fluid generation, and digital AI integration for remote patient monitoring. The company serves patients with chronic kidney disease and end-stage renal disease by providing portable and personalized treatment options.
Get Patensee, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Patensee, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access